Detalhe da pesquisa
1.
IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.
Nat Immunol
; 23(4): 532-542, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332327
2.
Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy.
Int J Cancer
; 141(7): 1458-1468, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28614908
3.
Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma.
Mol Ther
; 24(8): 1435-43, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27357626
4.
Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus.
Mol Ther
; 24(1): 175-83, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26310629
5.
Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma.
Int J Cancer
; 136(4): 945-54, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24975392
6.
Nucleotide modifications enable rational design of TLR7-selective ligands by blocking RNase cleavage.
J Exp Med
; 221(2)2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38095631
7.
Progress in vaccine development for infectious diseases-a Keystone Symposia report.
Ann N Y Acad Sci
; 1524(1): 65-86, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020354
8.
Corrigendum to "Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma".
Mol Ther
; 24(11): 2033, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27916990
9.
Oncolytic adenovirus decreases the proportion of TIM-3+ subset of tumor-infiltrating CD8+ T cells with correlation to improved survival in patients with cancer.
J Immunother Cancer
; 10(2)2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35193929
10.
Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase.
BMC Cancer
; 10: 7, 2010 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20055993
11.
Dexamethasone premedication suppresses vaccine-induced immune responses against cancer.
Oncoimmunology
; 9(1): 1758004, 2020 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923115
12.
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy.
Cancer Res
; 80(12): 2575-2585, 2020 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107211
13.
Artificially cloaked viral nanovaccine for cancer immunotherapy.
Nat Commun
; 10(1): 5747, 2019 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31848338
14.
Abscopal Effect in Non-injected Tumors Achieved with Cytokine-Armed Oncolytic Adenovirus.
Mol Ther Oncolytics
; 11: 109-121, 2018 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30569015
15.
Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients.
Oncotarget
; 9(5): 6320-6335, 2018 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29464075
16.
Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses.
JCI Insight
; 3(7)2018 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29618658
17.
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma.
Oncoimmunology
; 6(9): e1319028, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28932628
18.
Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy.
Oncoimmunology
; 6(2): e1265717, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28344872
19.
Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy.
Mol Ther Oncolytics
; 4: 77-86, 2017 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28345026
20.
Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models.
Cancer Immunol Res
; 5(2): 157-169, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28073775